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To determine the performance of combinations of structural and functional screening tests in 




505 subjects ≥ 60 years underwent: Frequency Doubling Technology (FDT) perimetry; iVue 
OCT (iWellness® and peripapillary retinal nerve fibre layer (RNFL) scans); IOP with the 
Ocular Response Analyzer (ORA), all performed by an ophthalmic technician. The reference 
standard was a full ophthalmic examination by an experienced clinician who was masked to 
the index test results. Subjects were classified as presence or absence of sight-threatening eye 
disease (clinically significant cataract, primary open angle glaucoma, intermediate or 
advanced AMD and significant diabetic retinopathy). Univariate and multivariate logistic 
regression was used to determine the association between abnormal screening test results and 
the presence of sight-threatening eye disease. 
 
Results 
171 subjects (33.8%) had one or more sight-threatening eye disease(s). The multivariate 
analysis found significant associations with any of the target conditions for visual acuity < 
6/12, an abnormal FDT and peripapillary RNFL thickness outside the 99% normal limit. The 
sensitivity of this optimised screening panel was 61.3% (95% CI 53.5-68.7); specificity 
78.8% (CI 74.0-83.1), positive predictive value 59.5% (CI 53.7-65.2) and an overall 
diagnostic accuracy of 72.9% (CI 68.8-76.8). 
 
Conclusion 
A subset of screening tests may provide an accurate and efficient means of population 
screening for significant eye disease in the elderly. This study provides useful preliminary 
data to inform the development of further larger, multicentre screening studies to validate this 
screening panel. 
